The fact that tumour cells escape from NK cell attack through the interaction of cell surface sialyl-decoration with Siglec7 and Siglec9 on NK cells makes the two lectins promising target in antitumor drug development. The gene discussed is SIGLEC9; the disease is neoplasm.